Panakeia
PrivateLast Round
Grant
Jul 1, 2024
Est. Valuation
$10.7M
Total Funding Raised
$9.49M
Company Overview
Panakeia is a biotechnology company that provides an AI-driven software platform for multi-omic biomarker profiling directly from tissue images to accelerate cancer diagnosis and inform precision treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Drug Discovery, Precision Medicine, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panakeia Comparables
Compare Panakeia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleai | 85% | |
| Imagene AI | 84% | |
| Aignostics | 81% | |
Panakeia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Grant | Apr 1, 2023 | ||||
| M&A | Sep 9, 2021 | ||||
| Seed | Oct 27, 2020 | ||||
| Grant | May 20, 2020 | ||||
Seed | Sep 26, 2019 |
Panakeia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Hoxton Ventures | Seed |
| Innovate UK | Grant |
| Phoenix Court Group | Seed |
| LocalGlobe | Seed |
| Entrepreneurs First | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Landmark metabolic and pathway activation data presented at AACR 2026.
- Apr 21, 2026
Presented new data at the AACR 2026 conference.
Panakeia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Panakeia's valuation, stock price, and market status.